Literature DB >> 19246970

Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.

G Corona1, E Mannucci, A D Fisher, F Lotti, E Bandini, L Vignozzi, G Balercia, F Paggi, L Petrone, G Forti, M Maggi.   

Abstract

General dynamic penile color doppler ultrasound (D-PCDU) screening in patients with erectile dysfunction (ED) has been questioned due to an inadequate cost-benefit ratio. The aim of the present study is to evaluate the validity of different risk scores in the identification of patients being screened for arteriogenic ED (AED) at D-PCDU. A consecutive series of 738 patients with ED was studied. AED was defined when peak systolic velocity (PSV) was lower than 25 cm/sec. The assessment of cardiovascular risk was evaluated using different risk engines, derived from the Framingham, the PROCAM and the Progetto Cuore studies. An iterative receiver operator characteristic (ROC) curve analysis was used to determine the most proper threshold for different scales for the screening of AED. Among the patients studied, 52 (7%) had PSV<25 cm/sec. The area under the ROC curves for pathological PSV in relation to cardiovascular risk estimated with different engines was 0.762+/-0.03, 0.716+/-0.03, and 0.667+/-0.03 for Progetto Cuore, Framingham, and PROCAM engines, respectively. Sensitivity and specificity of Progetto Cuore estimated risk were 67%, 71% when a threshold of 15% was chosen. Corresponding figures for Framingham and PROCAM engine were 74%, 57% and 69%, 55%, respectively. If D-PCDU is performed only on patients with cardiovascular risk >15%, who represent about 1/4 of all patients (26.8%), as estimated by Progetto Cuore, about 70% of cases of arteriogenic ED can be identified. Estimated cardiovascular risk, assessed through risk engines, could be used to identify patients who should undergo D-PCDU evaluation for the diagnosis of AED.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19246970     DOI: 10.1007/BF03345652

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

Review 1.  Colour Doppler ultrasound of the penis.

Authors:  C J Wilkins; S Sriprasad; P S Sidhu
Journal:  Clin Radiol       Date:  2003-07       Impact factor: 2.350

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

4.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

5.  The correlation of cavernous systolic occlusion pressure with peak velocity flow using color duplex Doppler ultrasound.

Authors:  E Rhee; A Osborn; M Witt
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450

Review 6.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.

Authors:  Piero Montorsi; Paolo M Ravagnani; Stefano Galli; Andrea Salonia; Alberto Briganti; José P Werba; Francesco Montorsi
Journal:  Eur Urol       Date:  2006-07-28       Impact factor: 20.096

7.  Comparison of duplex ultrasonography and nocturnal penile tumescence in evaluation of impotence.

Authors:  R P Allen; R M Engel; J K Smolev; C B Brendler
Journal:  J Urol       Date:  1994-06       Impact factor: 7.450

8.  Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.

Authors:  Francesco Montorsi; Alberto Briganti; Andrea Salonia; Patrizio Rigatti; Alberto Margonato; Andrea Macchi; Stefano Galli; Paolo M Ravagnani; Piero Montorsi
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

9.  A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction.

Authors:  Giovanni Corona; Edoardo Mannucci; Luisa Petrone; Claude Schulman; Giancarlo Balercia; Alessandra D Fisher; Valerio Chiarini; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2007-05       Impact factor: 3.802

Review 10.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

View more
  2 in total

Review 1.  Hypogonadism and metabolic syndrome.

Authors:  G Corona; G Rastrelli; A Morelli; L Vignozzi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-06-27       Impact factor: 4.256

2.  Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms.

Authors:  I Scavello; E Maseroli; S Cipriani; V Di Stasi; N Verde; D Menafra; S Scannerini; S Marchiani; G Rastrelli; V Ricca; F Sorbi; M Fambrini; F Petraglia; M Maggi; Linda Vignozzi
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.